A wnaiff yr Ysgrifennydd Cabinet gadarnhau a ellir rhagnodi cyffuriau fel Mounjaro (tirzepatide), neu Wegovy (semaglutide), ar gyfer colli pwysau ar GIG Cymru?
Weight loss drugs are available for prescription, across health boards, in Wales through specialist services as set out within the All-Wales Weight Management Pathway.
The All Wales Weight Management Pathway (Adult weight management pathway 2021 | GOV.WALES) sets out our approach to the development of weight management services for patients in Wales, from early intervention to specialist support, and is consistent with National Institute for Health and Care Excellence (NICE) guidance. An addendum to the guidance sets out that weight management medication can be prescribed by a specialist service, where clinically indicated and in combination with a behavioural (lifestyle) intervention that includes a reduced-calorie diet and increased physical activity.
Further information on tirzepatide (Mounjaro) for weight management, published by Welsh Health Circular in May, can be found here: Tirzepatide (Mounjaro®) for the management of obesity and overweight (WHC/2025/018) [HTML] | GOV.WALES